Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
!!T3 APO-AMOXI APOTEX INC Actual shortage 250MG Updated Report 2022-12-03 162918
PEN-VK AA PHARMA INC Resolved 300MG Updated Report 2022-12-03 175449
PRALUENT SANOFI-AVENTIS CANADA INC Actual shortage 150MG Updated Report 2022-12-03 176325
MYOZYME SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC Actual shortage 50MG Updated Report 2022-12-03 176406
MAR-METHIMAZOLE MARCAN PHARMACEUTICALS INC Actual shortage 5MG Updated Report 2022-12-03 176433
HEPARIN LEO INJ 1000UNIT/ML LEO PHARMA INC Actual shortage 1000UNIT Updated Report 2022-12-03 176999
CLINDAMYCIN INJECTION IN 5% DEXTROSE BAXTER CORPORATION Actual shortage 600MG Updated Report 2022-12-03 177050
ACH-ATORVASTATIN CALCIUM ACCORD HEALTHCARE INC Actual shortage 40MG Updated Report 2022-12-03 177024
ACH-PRAVASTATIN ACCORD HEALTHCARE INC Actual shortage 10MG Updated Report 2022-12-03 177027
ACH-OLMESARTAN ACCORD HEALTHCARE INC Actual shortage 40MG Updated Report 2022-12-03 177030

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
AMERGE GLAXOSMITHKLINE INC Discontinued 2.5MG Updated Report 2022-12-02 148430
XELODA CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 150MG Updated Report 2022-12-01 176355
XELODA CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 500MG Updated Report 2022-12-01 176359
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165397
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165462